ACUTE ISCHEMIC STROKE (AIS) MARKET ANALYSIS

Acute Ischemic Stroke (AIS) MarketSize and Trends

Global acute ischemic stroke (AIS) market is estimated to be valued at US$ 9.21 Bn in 2023, and is expected to exhibit a CAGR of 4.0% during the forecast period (2023-2030).

Figure 1. Global Acute Ischemic Stroke (AIS) Market Share (%), By Therapeutics, 2023

Figure 2. Global Acute Ischemic Stroke (AIS) Market Share(%), By Region, 2023

Global Acute Ischemic Stroke (AIS) Market: Trends

• Increasing inorganic growth strategies such as collaboration: Increasing inorganic growth strategies such as collaboration by research institutes is expected to drive the market growth over the forecast period. For instance, in October 2022, Assiut University, a university and research organization based in Asyut, Egypt, in collaboration with Aswan University Hospital, a university based in Egypt, initiated a clinical trial study to evaluate the efficiency of tissue plasminogen activator in acute stroke with COVID Virus in non-COVID-19 patients (rTPA). The clinical trial study is estimated to get completed by 2026.

Market Trends:

• Increasing inorganic growth strategies such as collaboration: Increasing inorganic growth strategies such as collaboration by research institutes is expected to drive the market growth over the forecast period. For instance, in October 2022, Assiut University, a university and research organization based in Asyut, Egypt, in collaboration with Aswan University Hospital, a university based in Egypt, initiated a clinical trial study to evaluate the efficiency of tissue plasminogen activator in acute stroke with COVID Virus in non-COVID-19 patients (rTPA). The clinical trial study is estimated to get completed by 2026.